Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Limited Cardiac Biomarker Testing Decreases Health Care Costs

By LabMedica International staff writers
Posted on 15 Jul 2014
Two relatively simple tactics have been used to significantly reduce the number of unnecessary blood tests to assess symptoms of heart attack and chest pain and to achieve a large decrease in patient charges.

Cardiac biomarkers, such as the total creatine kinase (CK), the isoenzymes MB-fractions of the creatine phosphokinase enzyme (CK-MB), and troponin, are frequently ordered in the emergency department (ED) and inpatient units to evaluate patients suspected of having an acute coronary syndrome (ACS).

Scientists at Johns Hopkins Bayview Medical Center (Baltimore, MD, USA) designed and implemented a multimodal intervention to improve evidence-based ordering of cardiac biomarkers for the diagnosis of acute coronary syndrome (ACS). More...
A total of 60,494 adult inpatient admissions from January 2009 through July 2011 (preintervention) and 24,341 admissions from November 2011 through October 2012 (postintervention) were included in the study.

The team targeted enabling factors by changing the computerized provider order entry system (Meditech; Westwood, MA, USA) by removing orders for CK and CK-MB from all standardized order sets and troponin orders from all order sets except two that are used for evaluation of new symptoms concerning ACS. They created a duplicate order pop-up warning when a troponin level was ordered sooner than six hours after another troponin level. They created pop-up warnings when a health provider attempted to order CK-MB or CK.

The primary outcome was percentage of patients with guideline-concordant ordering of cardiac biomarkers, defined as three or fewer troponin tests and zero CK-MB tests in patients without a diagnosis of ACS. Twelve months following the intervention, they estimated that guideline-concordant ordering of cardiac biomarkers increased from 57.1% to 95.5%, an absolute increase of 38.4%. They estimated that the intervention led to a 66% reduction in the number of tests ordered, and a decrease of USD 1.25 million in charges over the first year. At 12 months, there was an estimated absolute increase in incidence of primary diagnosis of ACS of 0.3 % compared with the expected baseline rate.

The authors concluded that by implementing a multimodal intervention they significantly increased guideline-concordant ordering of cardiac biomarker testing, leading to substantial reductions in tests ordered without impacting diagnostic yield. A trial of this approach at other institutions and for other diagnostic tests is warranted and if successful, would represent a framework for eliminating wasteful diagnostic testing.

Marc R. Larochelle, MD, the lead author of the study, said, “Through review of available evidence and reflection on our own practice, I believe we can proactively identify many practices that may be unnecessary and wasteful. We have demonstrated proof of concept that doctors can be leaders in delivering improved value for our patients and health care systems.” The study was published on June 28, 2014, in the Journal of General Internal Medicine.

Related Links:

Johns Hopkins Bayview Medical Center 
Meditech 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Electrolyte Analyzer
BKE-B
Gold Member
Aspiration System
VACUSAFE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.